These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11999571)

  • 41. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications.
    Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
    Blood; 1997 Mar; 89(5):1838-9. PubMed ID: 9057674
    [No Abstract]   [Full Text] [Related]  

  • 42. The role of cladribine in the treatment of lymphoid malignancies.
    Nelson MC; Hogan DK
    Oncol Nurs Forum; 1995 Oct; 22(9):1395-400. PubMed ID: 8539180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
    Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
    Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gynecomastia in a case of hairy cell leukaemia--cladribine induced?
    Abhyankar D; Saikia T; Advani S
    Leuk Lymphoma; 2001 Jun; 42(1-2):243-6. PubMed ID: 11699216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cladribine: from the bench to the bedside--focus on hairy cell leukemia.
    Greyz N; Saven A
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Criteria for use of cladribine in adults.
    Fedak MN
    Am J Hosp Pharm; 1994 Sep; 51(17):2185-6. PubMed ID: 7985700
    [No Abstract]   [Full Text] [Related]  

  • 47. The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia.
    Else M; Osuji N; Forconi F; Dearden C; Del Giudice I; Matutes E; Wotherspoon A; Lauria F; Catovsky D
    Cancer; 2007 Nov; 110(10):2240-7. PubMed ID: 17886250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.
    Zinzani PL; Magagnoli M; Bendandi M; Tani M; Stefoni V; Cellini C; Poggi S; Piccioli M; Pileri S; Tura S
    Haematologica; 2000 Sep; 85(9):922-5. PubMed ID: 10980629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cladribine in hairy cell leukemia.
    Belani R; Saven A
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia - lessons for immunopathogenesis and prescribing.
    Meher-Homji Z; Tam CS; Siderov J; Seymour JF; Holmes NE; Chua KYL; Phillips EJ; Slavin MA; Trubiano JA
    Leuk Lymphoma; 2019 Dec; 60(14):3455-3460. PubMed ID: 31256738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cladribine treatment of a patient with hairy cell leukemia and concomitant multiple sclerosis.
    Hilbe W; Berger T; Konwalinka G; Thaler J
    Acta Haematol; 1999; 102(2):99-100. PubMed ID: 10529514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hairy cell leukemia, Japanese variant, successfully treated with cladribine].
    Miyazaki M; Taguchi A; Sakuragi S; Mitani N; Matsuda K; Shinohara K
    Rinsho Ketsueki; 2004 May; 45(5):405-7. PubMed ID: 15199752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of cladribine at Scripps for hairy cell leukemia and current results.
    Torrey ML; Sigal DS; Saven A
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():29-33. PubMed ID: 21504293
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).
    Jehn U; Gawaz M; Grunewald R; Hill W; Lorenz B; Stôtzer O
    Anticancer Res; 1993; 13(5C):1809-14. PubMed ID: 7903521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hypersensitivity reactions to multiple drugs during the course of hairy cell leukemia treated with 2-chlorodeoxyadenosine].
    Kokunai A; Azusawa H; Murota H; Ohhata C; Katayama I; Murata S; Tadokoro S
    Arerugi; 2006 Jun; 55(6):662-6. PubMed ID: 16883103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [2-chlorodeoxyadenosine (2-CdA) cladribine therapy in hairy cell leukemia].
    Raanani P; Shpilberg O; Ben-Bassat I
    Harefuah; 1994 Jun; 126(11):673-6. PubMed ID: 7927005
    [No Abstract]   [Full Text] [Related]  

  • 57. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
    Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC).
    López Rubio M; Da Silva C; Loscertales J; Seri C; Baltasar P; Colado E; Pérez Fernández I; Osma M; Gomis F; González M; Jarque I; Vargas M; Monzó E; Monteagudo D; Orts MI; Pardal E; Carbonell F; Perez Calvo C; Garcia-Marco JA
    Leuk Lymphoma; 2014 May; 55(5):1007-12. PubMed ID: 23885799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complete recovery of pyoderma gangrenosum after successful treatment of underlying hairy cell leukemia with cladribine.
    Tombak A; Aygün S; Serinsöz E; Tiftik EN
    Korean J Intern Med; 2015 Sep; 30(5):739-41. PubMed ID: 26354071
    [No Abstract]   [Full Text] [Related]  

  • 60. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
    Palomera L; Domingo JM; Sola C; Azaceta G; Calvo MT; Gutierrez M
    Haematologica; 2002 Jan; 87(1):107-8. PubMed ID: 11801472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.